Academic Exchanges between PUTH and ACC on the Co-treatment of Diabetes and Heart Disease held
Peking: On September 26, the 2020 Academic Exchange Conference on Co-treatment of Diabetes and Heart Disease, jointly organized by the Department of Cardiology of Peking University Third Hospital (PUTH) and the American College of Cardiology (ACC), was held in Beijing. More than 30 experts and scholars in the field of metabolic cardiology from dozens of hospitals in China, including Fuwai Hospital of Chinese Academy of Medical Sciences, Beijing Anzhen Hospital, Peking University People’s Hospital, Peking Union Medical College Hospital and PUTH, attended the meeting.
At the meeting, experts from China and the United States discussed many issues related to diabetes and cardiovascular disease, sharing clinical research results and exploring the road to building a cardiovascular metabolic center based on multidisciplinary cooperation. The US co-chair group is composed of three ACC experts: Professor Michael J. Blaha of Johns Hopkins University Heart Center, Professor Pam R. Taub of UC San Diego Medical Center and Professor Neha J. Pagidipati of Duke University Medical Center, who gave lectures through remote video on three topics respectively: the new management mode for type 2 diabetes patients with cardiovascular disease, the new hypoglycemic drug CVOT and cardiovascular disease, and the reduction of cardiovascular risk factors in patients with type 2 diabetes.
Professor Tang Yida, leader of the Metabolic Cardiovascular Disease Group of the Cardiovascular Branch under the Chinese Medical Association (CMA) and dean of the Department of Cardiovascular Medicine of PUTH, pointed out that metabolic cardiovascular disease is one of the hot research fields in cardiology. As a “three high” disease-stricken country, China has formed a comprehensive disease management mode through multi-disciplinary cooperation to prevent cardiovascular disease, which can significantly reduce the threat of the disease to patient lives and reduce its social and economic burden.
Experts at the meeting emphasized the significance of individualized and comprehensive management for heart disease patients with multiple metabolic risk factors. They all agreed that, only by establishing a cardiovascular metabolism outpatient service, integrating medical resources, cooperating with various disciplines and co-managing multiple factors, can such patients get the maximum benefit.